Chemomab Therapeutics Ltd. Deferred Tax Assets, Capital Loss Carryforwards
Chemomab Therapeutics Ltd. (CMMB) had Deferred Tax Assets, Capital Loss Carryforwards of $3.27 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-03-23
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.27M.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $0.00; Deferred Tax Assets, Capital Loss Carryforwards as first filed $14.22M.
- 2020-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.64M.
- 2019-12-31: Deferred Tax Assets, Capital Loss Carryforwards $3.42M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $3.27M 20-F · filed 2026-03-23 | |
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 | $14.22M 20-F · filed 2025-04-04 |
| 2020-12-31 | $3.64M 10-K · filed 2021-03-09 | |
| 2019-12-31 | $3.42M 10-K · filed 2021-03-09 | |
| 2018-12-31 | $3.15M 10-K · filed 2020-03-17 |